Q3-osavuosiraportti
Vain PDF
10 päivää sitten
Tarjoustasot
First North Sweden
Määrä
Osto
17 697
Myynti
Määrä
17 332
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 73 | - | - | ||
| 1 137 | - | - | ||
| 1 166 | - | - | ||
| 300 | - | - | ||
| 10 000 | - | - |
Ylin
1,365VWAP
Alin
1,31VaihtoMäärä
0 25 639
VWAP
Ylin
1,365Alin
1,31VaihtoMäärä
0 25 639
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 25 639 | 25 639 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 25 639 | 25 639 | 0 | 0 |
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q3-osavuosiraportti | 20.11. 6 päivää |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 4.11. | |
| 2025 Q2-osavuosiraportti | 21.8. | |
| 2024 Yhtiökokous | 3.6. | |
| 2025 Q1-osavuosiraportti | 15.5. | |
| 2024 Q4-osavuosiraportti | 20.2. |
Datan lähde: Millistream, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·8.11. · Muokattu(Update of the deleted post.) With the current price of 1.40 SEK, one gets the entire unlisted stock portfolio almost for free. For 12 öre, one gets unlisted shares valued at 4.08 SEK. Thus, a discount of 97 % - when calculating the real intrinsic value the way I do it (See below.) It was indeed a surprise to read the plans for an issue - but fundamentally nothing has changed. The price has just plummeted - and the discount has increased. The issue is not a sign of crisis, but a desire to reinvest. But foolish to make it a preferential issue, which makes the price plummet as if it were a biotech stock issue, instead of having carried out a directed issue. Now the price very easily ends up around the issue price - and perhaps even lower for a period immediately after the issue, if guarantors receive an additional discount - even though the price is already completely insane. But that's usually how it always goes when an issue is handled incorrectly. Right now there's a bargain on the stock. But if one is not long-term, or does not have the money to buy more or to participate in the issue, it is a really tough situation right now. And what will the intrinsic value discount look like after the issue? If the issue is fully successful and based on today's price of 1.4, the new theoretical price will be approx. 1.38. If the net proceeds after costs and discount amount to 22 mio. and the 10 mio. are invested, we end up with a real intrinsic value discount of 90 %. Calculation method: I calculate the real intrinsic value discount solely in relation to the unlisted shares, by first fully offsetting the value of the listed shares as well as positive capital including receivables (and offsetting any debt.) After that, it is of course necessary to look at what unlisted shares are in the company's portfolio. Firstly, one must consider whether the value is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management trustworthy and competent, including the extent to which the management itself invests, and whether there are larger investors who sometimes supplement further. (Although the latter is the case with this stock – and is generally positive – I have conversely written previously that precisely with this stock I can be a little concerned that it might one day lead to a takeover and redemption of the small shareholders, if the small shareholders continuously divest this stock.) Secondly, one must consider the security in relation to how much individual stocks make up in the portfolio. In this stock, the 3 largest unlisted companies together constitute “only” approx. 50 % of the unlisted shares. So that doesn't worry me. So even if all 3 largest companies were to go bankrupt, the stock's intrinsic value would still be intact relative to the price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And that must of course be included in the overall assessment.- 8.11.8.11.Tämä julkaisu on poistettu.
·7.11.Agree. The discount has increased and suddenly there is an offering of positions that makes it possible to increase holdings cheaply, which I have taken the opportunity to do. Cannot assess the two companies that 2•5mkr will go into, but I assume that M2 and Roos-gruppen do not hate money and that they therefore also use the liquidity of 15 mkr selectively and wisely (and good to avoid selling Humble at the current level to finance the management). In that case, the revaluation can be fantastic the day values are realized (and thereby confidence returns) in one of the promising unlisted companies, e.g. Zigrid o/e Mendi 👌🙏 💰! At the same time, the risk must be considered limited given the discount and the diversification in the portfolio. - ·26.10.The share price is fortunately rising, but with low turnover. The official NAV discount is approx. 65 %. But that's not how I calculate it. The real NAV discount is well over 75 %. I calculate the real NAV discount solely in relation to the unlisted shares, as I first fully offset the value of the listed shares and liquid positive capital (and offset any debt). After that, it is of course necessary to look at what unlisted shares are held in the company's portfolio. Firstly, one must consider whether the valuation is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management trustworthy and competent, including to what extent the management itself invests, and whether there are larger investors who sometimes top up further. (Although the latter is the case for this share – and is generally positive – I have conversely written previously that precisely for this share I may be a little concerned that it might one day lead to a takeover and redemption of minority shareholders, if minority shareholders continuously divest this share.) Secondly, one must consider the security in relation to how much individual shares make up in the portfolio. In this share, the 3 largest unlisted companies together constitute "only" approx. 50 % of the unlisted shares. So that doesn't worry me. So even if all 3 largest companies were to go bankrupt, the share's intrinsic value would still be intact relative to the share price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And that must, of course, be included in the overall assessment. In comparison, Umecrine alone accounts for almost 55 % of the unlisted shares in Karolinska Development (which I also invest in), which some believe is the reason for the large NAV discount in this company of approx. 80 %. But also in Karolinska Development, the large NAV discount more than sufficiently accounts for Umecrine unexpectedly being worth 0 kr. I have tried using the same method to assess the real NAV discount in Kinnevik (which is currently rising sharply in price) compared to First Venture. The official NAV discount is approx. 35 %. The real NAV discount is approx. 45 % according to my calculation. At Kinnevik, the 3 largest unlisted companies account for approx. 43 % of the unlisted shares, and in this respect are somewhat similar to First Venture. But the portfolio is broader in Kinnevik – and the share capital is of a quite different size, and the administrative expenses as a percentage of the market value are correspondingly much lower. My trust in the management, however, is not very high, as I still wonder about the wisdom of selling the golden egg and now instead holding 7.7 billion in uninvested capital, instead of having continuously sold off the golden egg when needed and when there were companies one would rather invest the money in. But others may have greater abilities than I do to assess the value of the underlying unlisted companies in the three mentioned listed companies.
- ·7.10. · MuokattuI'm actually more afraid that the share is so cheap at the moment that it will slowly be bought up, and one day, when the hidden values come to light, we will be forcibly redeemed by the large owners. So I hope that the small shareholders buy in well before the shares disappear. See for example: Investment company First Ventures' largest owner, real estate profile Rutger Arnhult has increased his ownership in the company by 2.1 million shares. He now owns just over 10 million shares, corresponding to 26.7 percent of the capital
·8.10.The bottom of the supply has been increasing in any case. I have a GAK of around 1.65 and it makes up about 4 percent of the portfolio.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Q3-osavuosiraportti
Vain PDF
10 päivää sitten
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·8.11. · Muokattu(Update of the deleted post.) With the current price of 1.40 SEK, one gets the entire unlisted stock portfolio almost for free. For 12 öre, one gets unlisted shares valued at 4.08 SEK. Thus, a discount of 97 % - when calculating the real intrinsic value the way I do it (See below.) It was indeed a surprise to read the plans for an issue - but fundamentally nothing has changed. The price has just plummeted - and the discount has increased. The issue is not a sign of crisis, but a desire to reinvest. But foolish to make it a preferential issue, which makes the price plummet as if it were a biotech stock issue, instead of having carried out a directed issue. Now the price very easily ends up around the issue price - and perhaps even lower for a period immediately after the issue, if guarantors receive an additional discount - even though the price is already completely insane. But that's usually how it always goes when an issue is handled incorrectly. Right now there's a bargain on the stock. But if one is not long-term, or does not have the money to buy more or to participate in the issue, it is a really tough situation right now. And what will the intrinsic value discount look like after the issue? If the issue is fully successful and based on today's price of 1.4, the new theoretical price will be approx. 1.38. If the net proceeds after costs and discount amount to 22 mio. and the 10 mio. are invested, we end up with a real intrinsic value discount of 90 %. Calculation method: I calculate the real intrinsic value discount solely in relation to the unlisted shares, by first fully offsetting the value of the listed shares as well as positive capital including receivables (and offsetting any debt.) After that, it is of course necessary to look at what unlisted shares are in the company's portfolio. Firstly, one must consider whether the value is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management trustworthy and competent, including the extent to which the management itself invests, and whether there are larger investors who sometimes supplement further. (Although the latter is the case with this stock – and is generally positive – I have conversely written previously that precisely with this stock I can be a little concerned that it might one day lead to a takeover and redemption of the small shareholders, if the small shareholders continuously divest this stock.) Secondly, one must consider the security in relation to how much individual stocks make up in the portfolio. In this stock, the 3 largest unlisted companies together constitute “only” approx. 50 % of the unlisted shares. So that doesn't worry me. So even if all 3 largest companies were to go bankrupt, the stock's intrinsic value would still be intact relative to the price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And that must of course be included in the overall assessment.
- 8.11.8.11.Tämä julkaisu on poistettu.·7.11.Agree. The discount has increased and suddenly there is an offering of positions that makes it possible to increase holdings cheaply, which I have taken the opportunity to do. Cannot assess the two companies that 2•5mkr will go into, but I assume that M2 and Roos-gruppen do not hate money and that they therefore also use the liquidity of 15 mkr selectively and wisely (and good to avoid selling Humble at the current level to finance the management). In that case, the revaluation can be fantastic the day values are realized (and thereby confidence returns) in one of the promising unlisted companies, e.g. Zigrid o/e Mendi 👌🙏 💰! At the same time, the risk must be considered limited given the discount and the diversification in the portfolio.
- ·26.10.The share price is fortunately rising, but with low turnover. The official NAV discount is approx. 65 %. But that's not how I calculate it. The real NAV discount is well over 75 %. I calculate the real NAV discount solely in relation to the unlisted shares, as I first fully offset the value of the listed shares and liquid positive capital (and offset any debt). After that, it is of course necessary to look at what unlisted shares are held in the company's portfolio. Firstly, one must consider whether the valuation is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management trustworthy and competent, including to what extent the management itself invests, and whether there are larger investors who sometimes top up further. (Although the latter is the case for this share – and is generally positive – I have conversely written previously that precisely for this share I may be a little concerned that it might one day lead to a takeover and redemption of minority shareholders, if minority shareholders continuously divest this share.) Secondly, one must consider the security in relation to how much individual shares make up in the portfolio. In this share, the 3 largest unlisted companies together constitute "only" approx. 50 % of the unlisted shares. So that doesn't worry me. So even if all 3 largest companies were to go bankrupt, the share's intrinsic value would still be intact relative to the share price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And that must, of course, be included in the overall assessment. In comparison, Umecrine alone accounts for almost 55 % of the unlisted shares in Karolinska Development (which I also invest in), which some believe is the reason for the large NAV discount in this company of approx. 80 %. But also in Karolinska Development, the large NAV discount more than sufficiently accounts for Umecrine unexpectedly being worth 0 kr. I have tried using the same method to assess the real NAV discount in Kinnevik (which is currently rising sharply in price) compared to First Venture. The official NAV discount is approx. 35 %. The real NAV discount is approx. 45 % according to my calculation. At Kinnevik, the 3 largest unlisted companies account for approx. 43 % of the unlisted shares, and in this respect are somewhat similar to First Venture. But the portfolio is broader in Kinnevik – and the share capital is of a quite different size, and the administrative expenses as a percentage of the market value are correspondingly much lower. My trust in the management, however, is not very high, as I still wonder about the wisdom of selling the golden egg and now instead holding 7.7 billion in uninvested capital, instead of having continuously sold off the golden egg when needed and when there were companies one would rather invest the money in. But others may have greater abilities than I do to assess the value of the underlying unlisted companies in the three mentioned listed companies.
- ·7.10. · MuokattuI'm actually more afraid that the share is so cheap at the moment that it will slowly be bought up, and one day, when the hidden values come to light, we will be forcibly redeemed by the large owners. So I hope that the small shareholders buy in well before the shares disappear. See for example: Investment company First Ventures' largest owner, real estate profile Rutger Arnhult has increased his ownership in the company by 2.1 million shares. He now owns just over 10 million shares, corresponding to 26.7 percent of the capital·8.10.The bottom of the supply has been increasing in any case. I have a GAK of around 1.65 and it makes up about 4 percent of the portfolio.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
17 697
Myynti
Määrä
17 332
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 73 | - | - | ||
| 1 137 | - | - | ||
| 1 166 | - | - | ||
| 300 | - | - | ||
| 10 000 | - | - |
Ylin
1,365VWAP
Alin
1,31VaihtoMäärä
0 25 639
VWAP
Ylin
1,365Alin
1,31VaihtoMäärä
0 25 639
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 25 639 | 25 639 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 25 639 | 25 639 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q3-osavuosiraportti | 20.11. 6 päivää |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 4.11. | |
| 2025 Q2-osavuosiraportti | 21.8. | |
| 2024 Yhtiökokous | 3.6. | |
| 2025 Q1-osavuosiraportti | 15.5. | |
| 2024 Q4-osavuosiraportti | 20.2. |
Datan lähde: Millistream, Quartr
Q3-osavuosiraportti
Vain PDF
10 päivää sitten
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q3-osavuosiraportti | 20.11. 6 päivää |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 4.11. | |
| 2025 Q2-osavuosiraportti | 21.8. | |
| 2024 Yhtiökokous | 3.6. | |
| 2025 Q1-osavuosiraportti | 15.5. | |
| 2024 Q4-osavuosiraportti | 20.2. |
Datan lähde: Millistream, Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·8.11. · Muokattu(Update of the deleted post.) With the current price of 1.40 SEK, one gets the entire unlisted stock portfolio almost for free. For 12 öre, one gets unlisted shares valued at 4.08 SEK. Thus, a discount of 97 % - when calculating the real intrinsic value the way I do it (See below.) It was indeed a surprise to read the plans for an issue - but fundamentally nothing has changed. The price has just plummeted - and the discount has increased. The issue is not a sign of crisis, but a desire to reinvest. But foolish to make it a preferential issue, which makes the price plummet as if it were a biotech stock issue, instead of having carried out a directed issue. Now the price very easily ends up around the issue price - and perhaps even lower for a period immediately after the issue, if guarantors receive an additional discount - even though the price is already completely insane. But that's usually how it always goes when an issue is handled incorrectly. Right now there's a bargain on the stock. But if one is not long-term, or does not have the money to buy more or to participate in the issue, it is a really tough situation right now. And what will the intrinsic value discount look like after the issue? If the issue is fully successful and based on today's price of 1.4, the new theoretical price will be approx. 1.38. If the net proceeds after costs and discount amount to 22 mio. and the 10 mio. are invested, we end up with a real intrinsic value discount of 90 %. Calculation method: I calculate the real intrinsic value discount solely in relation to the unlisted shares, by first fully offsetting the value of the listed shares as well as positive capital including receivables (and offsetting any debt.) After that, it is of course necessary to look at what unlisted shares are in the company's portfolio. Firstly, one must consider whether the value is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management trustworthy and competent, including the extent to which the management itself invests, and whether there are larger investors who sometimes supplement further. (Although the latter is the case with this stock – and is generally positive – I have conversely written previously that precisely with this stock I can be a little concerned that it might one day lead to a takeover and redemption of the small shareholders, if the small shareholders continuously divest this stock.) Secondly, one must consider the security in relation to how much individual stocks make up in the portfolio. In this stock, the 3 largest unlisted companies together constitute “only” approx. 50 % of the unlisted shares. So that doesn't worry me. So even if all 3 largest companies were to go bankrupt, the stock's intrinsic value would still be intact relative to the price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And that must of course be included in the overall assessment.
- 8.11.8.11.Tämä julkaisu on poistettu.·7.11.Agree. The discount has increased and suddenly there is an offering of positions that makes it possible to increase holdings cheaply, which I have taken the opportunity to do. Cannot assess the two companies that 2•5mkr will go into, but I assume that M2 and Roos-gruppen do not hate money and that they therefore also use the liquidity of 15 mkr selectively and wisely (and good to avoid selling Humble at the current level to finance the management). In that case, the revaluation can be fantastic the day values are realized (and thereby confidence returns) in one of the promising unlisted companies, e.g. Zigrid o/e Mendi 👌🙏 💰! At the same time, the risk must be considered limited given the discount and the diversification in the portfolio.
- ·26.10.The share price is fortunately rising, but with low turnover. The official NAV discount is approx. 65 %. But that's not how I calculate it. The real NAV discount is well over 75 %. I calculate the real NAV discount solely in relation to the unlisted shares, as I first fully offset the value of the listed shares and liquid positive capital (and offset any debt). After that, it is of course necessary to look at what unlisted shares are held in the company's portfolio. Firstly, one must consider whether the valuation is correctly determined. I do not have the prerequisites to know this, and must therefore assess whether I find the management trustworthy and competent, including to what extent the management itself invests, and whether there are larger investors who sometimes top up further. (Although the latter is the case for this share – and is generally positive – I have conversely written previously that precisely for this share I may be a little concerned that it might one day lead to a takeover and redemption of minority shareholders, if minority shareholders continuously divest this share.) Secondly, one must consider the security in relation to how much individual shares make up in the portfolio. In this share, the 3 largest unlisted companies together constitute "only" approx. 50 % of the unlisted shares. So that doesn't worry me. So even if all 3 largest companies were to go bankrupt, the share's intrinsic value would still be intact relative to the share price. But the low capital in the company and the low market value make the administrative expenses extremely high as a percentage of the market value, as another debater has pointed out. And that must, of course, be included in the overall assessment. In comparison, Umecrine alone accounts for almost 55 % of the unlisted shares in Karolinska Development (which I also invest in), which some believe is the reason for the large NAV discount in this company of approx. 80 %. But also in Karolinska Development, the large NAV discount more than sufficiently accounts for Umecrine unexpectedly being worth 0 kr. I have tried using the same method to assess the real NAV discount in Kinnevik (which is currently rising sharply in price) compared to First Venture. The official NAV discount is approx. 35 %. The real NAV discount is approx. 45 % according to my calculation. At Kinnevik, the 3 largest unlisted companies account for approx. 43 % of the unlisted shares, and in this respect are somewhat similar to First Venture. But the portfolio is broader in Kinnevik – and the share capital is of a quite different size, and the administrative expenses as a percentage of the market value are correspondingly much lower. My trust in the management, however, is not very high, as I still wonder about the wisdom of selling the golden egg and now instead holding 7.7 billion in uninvested capital, instead of having continuously sold off the golden egg when needed and when there were companies one would rather invest the money in. But others may have greater abilities than I do to assess the value of the underlying unlisted companies in the three mentioned listed companies.
- ·7.10. · MuokattuI'm actually more afraid that the share is so cheap at the moment that it will slowly be bought up, and one day, when the hidden values come to light, we will be forcibly redeemed by the large owners. So I hope that the small shareholders buy in well before the shares disappear. See for example: Investment company First Ventures' largest owner, real estate profile Rutger Arnhult has increased his ownership in the company by 2.1 million shares. He now owns just over 10 million shares, corresponding to 26.7 percent of the capital·8.10.The bottom of the supply has been increasing in any case. I have a GAK of around 1.65 and it makes up about 4 percent of the portfolio.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
17 697
Myynti
Määrä
17 332
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 73 | - | - | ||
| 1 137 | - | - | ||
| 1 166 | - | - | ||
| 300 | - | - | ||
| 10 000 | - | - |
Ylin
1,365VWAP
Alin
1,31VaihtoMäärä
0 25 639
VWAP
Ylin
1,365Alin
1,31VaihtoMäärä
0 25 639
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 25 639 | 25 639 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 25 639 | 25 639 | 0 | 0 |